SCHEMBL22155152

SCHEMBL22155152

c1ccc(-c2cccc(-c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4c4cc6c(cc54)oc4ccc5ccccc5c46)c4ccccc34)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.42
CYP1A1 P04798 3/20 0.42
CYP1A2 P05177 3/20 0.42
AHR P35869 2/20 0.42
PAX8 Q06710 2/20 0.42
FYN P06241 1/20 0.42
MAPK3 P27361 1/20 0.42
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
PLA2G10 O15496 1/20 0.37
PGR P06401 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
CYP1B1 Q16678 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PDE5A O76074 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22155124 0.95 ABCG2 (0.39) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155521 0.95 ABCG2 (0.42) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155073 0.95 ABCG2 (0.44) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155447 0.94 ABCG2 (0.39) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155068 0.94 ABCG2 (0.39) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155448 0.94 ABCG2 (0.45) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155172 0.93 ABCG2 (0.39) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155549 0.93 ABCG2 (0.42) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL22155081 0.92 ABCG2 (0.44) ABCG2CYP1A1CYP1A2AHRPAX8
SCHEMBL20127314 0.92 ABCG2 (0.43) ABCG2CYP1A1CYP1A2AHRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 ABCG2 433/4885CYP1A1 884/4885CYP1A2 911/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 ABCG2 433/4885CYP1A1 884/4885CYP1A2 911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.